Theranica Bio-Electronics LTD

Theranica develops advanced, clinically proven, safe and affordable electroceuticals, addressing a few of world's most prevalent neurological pain diseases.
The company's first product, Nerivio, is an innovative FDA-authorized, non-invasive, smartphone-operated, prescribed wearable for the acute treatment of migraine in patients 12 years of age or older. In November 2019 Nerivio was named one of TIME's 100 Best Inventions of the year under the healthcare category.

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved